Skip to main content
. 2015 May 18;2015:185859. doi: 10.1155/2015/185859

Table 1.

Characteristics of respondents.

All patients Thyroid disease status Celiac disease status
No thyroid disease Autoantibodies + normal TSH (T1D + AB, untreated) Autoantibodies + high TSH upon diagnosis
(T1D + AITD, treated)
No celiac disease Celiac disease (T1D + CD)
n 248 143 (57.6%) 65 (26.2%) 40 (16.1%) 222 (89.5%) 26 (10.5%)

Females (n, %) 118 (47.6%) 63 (44.0%) 27 (41.5%) 28 (70.0%)a 104 (46.8%) 14 (53.8%)
Age (years) 13.7 (11.6–16.6) 13.3 (11.3–16.0) 14.0 (10.9–16.7) 15.2 (13.2–17.2)b 13.4 (11.7–13.9) 13.4 (11.7–13.9)
T1D treatment
 Insulin pen 156 90 39 27 142 14
 Insulin pump 96 (38.7%) 53 (37.0%) 26 (40.0%) 13 (32.5%) 80 (36.0%) 12 (46.1%)
HbA1c (mmol/mol IFCC) 68 (60–77) 67 (60–75) 66 (60–76) 75 (63–82)c 68 (60–77) 72 (60–83)
Diabetes duration (years) 6.3 (3.0–9.3) 5.8 (2.8–9.3) 5.7 (2.8–8.8) 7.8 (5.2–10.6) 5.9 (2.8–9.3) 7.6 (4.9–9.1)

Data are described as median (interquartile range) or n (%).

a P = 0.0065 as compared to subjects with no thyroid disease; b P = 0.0017 as compared to subjects with no thyroid disease; c P = 0.044 as compared to subjects with no thyroid disease.